Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis

Show other versions (1)

The efficacy of Bacillus Calmette-Guerin (BCG) vaccination in protection against pulmonary tuberculosis (TB) is highly variable between populations. One possible explanation for this variability is increased exposure of certain populations to non-tuberculous mycobacteria (NTM). This study used a mur...

Full description

Bibliographic Details
Main Authors:	Poyntz, H, Stylianou, E, Griffiths, K, Marsay, L, Checkley, A, McShane, H
Format:	Journal article
Published:	2014

Similar Items

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
by: Poyntz, H, et al.
Published: (2014)

Evaluation of immunological mechanisms induced by Mycobacterium avium exposure and the effect upon pre-existing BCG immunity
by: Poyntz, H, et al.
Published: (2011)

Measuring exposure to non-tuberculous mycobacteria: defining and testing novel antigens
by: Checkley, A, et al.
Published: (2012)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
by: Griffiths, K, et al.
Published: (2013)

Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.
by: Checkley, A, et al.
Published: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
by: Marsay, L, et al.
Published: (2013)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
by: Griffiths, K, et al.
Published: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
by: Marsay, L, et al.
Published: (2013)

Tuberculosis vaccines: Progress and challenges
by: Checkley, A, et al.
Published: (2011)

Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.
by: Anna M Checkley, et al.
Published: (2011-01-01)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice.
by: Kristin L Griffiths, et al.
Published: (2013-01-01)

Cobalamin is present in cells of non-tuberculous mycobacteria, but not in Mycobacterium tuberculosis
by: Alina Minias, et al.
Published: (2021-06-01)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
by: Stylianou, E, et al.
Published: (2015)

Tuberculosis vaccines: progress and challenges.
by: Checkley, A, et al.
Published: (2011)

Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection
by: Stylianou, E, et al.
Published: (2011)

Differential Responses by Human Macrophages to Infection With Mycobacterium tuberculosis and Non-tuberculous Mycobacteria
by: Zhihong Feng, et al.
Published: (2020-02-01)

Metabolic activity of mature biofilms of Mycobacterium tuberculosis and other non-tuberculous mycobacteria
by: Anna Solokhina, et al.
Published: (2017-08-01)

Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions
by: Deepshikha Verma, et al.
Published: (2020-11-01)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
by: Poyntz, HC
Published: (2012)

The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life.
by: Burl, S, et al.
Published: (2010)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
by: Minassian, A, et al.
Published: (2011)

Mycobacteria-Specific T Cells Are Generated in the Lung During Mucosal BCG Immunization or Infection With Mycobacterium tuberculosis
by: Juan I. Basile, et al.
Published: (2020-10-01)

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
by: Williams, A, et al.
Published: (2005)

Role of GenoType® Mycobacterium Common Mycobacteria/Additional Species Assay for Rapid Differentiation between Mycobacterium tuberculosis Complex and Different Species of Non-tuberculous Mycobacteria
by: Amresh Kumar Singh, et al.
Published: (2013-07-01)

Rapid Immunochromatographic Test for the Identification and Discrimination of Mycobacterium tuberculosis Complex Isolates from Non-tuberculous Mycobacteria
by: Vishnu Prasad Shenoy, et al.
Published: (2014-04-01)

Validation of biomarkers for distinguishing Mycobacterium tuberculosis from non-tuberculous mycobacteria using gas chromatography-mass spectrometry and chemometrics.
by: Ngoc A Dang, et al.
Published: (2013-01-01)

Antimycobacterial Activity of <i>Hedeoma drummondii</i> against <i>Mycobacterium tuberculosis</i> and Non-Tuberculous Mycobacteria
by: Carmen Molina-Torres, et al.
Published: (2023-04-01)

First report of occurrence of Mycobacterium tuberculosis and Non-tuberculous mycobacteria in a heterozygous carrier of chronic granulomatous patient
by: Dina Soroush, et al.
Published: (2015-01-01)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
by: Satti, I, et al.
Published: (2022)

Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis.
by: Mark Hatherill, et al.
Published: (2006-12-01)

Vaccination against tuberculosis: how can we better BCG?
by: Pitt, J, et al.
Published: (2013)

Vaccination against tuberculosis: How can we better BCG?
by: Pitt, J, et al.
Published: (2013)

The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life.
by: Sarah Burl, et al.
Published: (2010-08-01)

Editorial: Genomics-based strategies for advanced drug resistance and epidemiological surveillance of Mycobacterium tuberculosis and other non-tuberculous mycobacteria
by: Arash Ghodousi, et al.
Published: (2023-08-01)

Understanding BCG is the key to improving it.
by: McShane, H
Published: (2013)

Revaccination with BCG: does it work?
by: McShane, H
Published: (2024)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
by: Harris, SA, et al.
Published: (2014)

Sarcoidosis: Role of non-tuberculosis mycobacteria and Mycobacterium tuberculosis
by: Esmaeil Mortaz, et al.
Published: (2014-01-01)

Profile of non-tuberculous mycobacteria amongst tuberculosis presumptive people in Cameroon
by: Valerie Flore Donkeng Donfack, et al.
Published: (2024-03-01)

Editorial: Tuberculosis and Non-tuberculous Mycobacteria Infections: Control, Diagnosis and Treatment
by: Onya Opota, et al.
Published: (2021-10-01)